Literature DB >> 28452861

Inadequate Gestational Weight Gain, the Hidden Link Between Maternal IBD and Adverse Pregnancy Outcomes: Results from the Norwegian Mother and Child Cohort Study.

May-Bente Bengtson1, Geir Aamodt, Uma Mahadevan, Morten H Vatn.   

Abstract

BACKGROUND: Patients with inflammatory bowel disease (IBD) are in general prone to weight loss. We explored the risk of inadequate gestational weight gain (GWG), and the impact of GWG on adverse pregnancy outcomes, among mothers with IBD in the Norwegian Mother and Child Cohort Study (MoBa).
METHODS: The MoBa with 95,200 mothers enrolled from 1999 to 2008, comprised 217 mothers with ulcerative colitis and 166 with Crohn's disease. Demographics were ascertained through a basic questionnaire before the first ultrasound visit and an IBD history and disease activity during pregnancy through a questionnaire mailed out in 2013. Inadequate GWG was based on the US Institute of Medicine recommendations. The associations between IBD and inadequate GWG or adverse pregnancy outcomes were explored, adjusted for diabetes, hypertension, smoking, maternal age, education, and disease activity.
RESULTS: Mothers with Crohn's disease (34.3%) and ulcerative colitis (26.7%) were more frequently exposed to inadequate GWG compared with non-IBD mothers (19.4%) (adjusted odds ratio [aOR] = 2.02, 95% confidence interval [CI], 1.42-2.86 and aOR = 1.46, 95% CI, 1.04-2.05, respectively). Mothers with IBD with inadequate GWG (exposed) had a 2-fold risk of small for gestational age infants compared with exposed non-IBD mothers (aOR = 1.93, 95% CI, 1.13-3.29). Exposed mothers with Crohn's disease and ulcerative colitis had a several-fold increased risk of small for gestational age compared with nonexposed IBD mothers (aOR = 4.5, 95% CI, 1.3-16.2, aOR = 5.5, 95% CI, 1.6-18.5). Disease activity was associated with reduced GWG (<13 kg compared with >17.5 kg) (aOR = 3.34, 95% CI, 1.33-8.38).
CONCLUSIONS: Inadequate GWG should be considered as a risk factor for adverse pregnancy outcomes or as a marker of disease activity.

Entities:  

Mesh:

Year:  2017        PMID: 28452861     DOI: 10.1097/MIB.0000000000001123

Source DB:  PubMed          Journal:  Inflamm Bowel Dis        ISSN: 1078-0998            Impact factor:   5.325


  7 in total

1.  Dietary Patterns in women with Inflammatory Bowel Disease and Risk of Adverse Pregnancy Outcomes: Results from The Norwegian Mother and Child Cohort Study (MoBa).

Authors:  Thea Myklebust-Hansen; Geir Aamodt; Margaretha Haugen; Anne Lise Brantsæter; Morten H Vatn; May-Bente Bengtson
Journal:  Inflamm Bowel Dis       Date:  2017-12-19       Impact factor: 5.325

Review 2.  Inflammatory Bowel Disease and Reproductive Health: From Fertility to Pregnancy-A Narrative Review.

Authors:  Camilla Ronchetti; Federico Cirillo; Noemi Di Segni; Martina Cristodoro; Andrea Busnelli; Paolo Emanuele Levi-Setti
Journal:  Nutrients       Date:  2022-04-12       Impact factor: 6.706

3.  Lower Abundance and Impaired Function of CD71+ Erythroid Cells in Inflammatory Bowel Disease Patients During Pregnancy.

Authors:  Garett Dunsmore; Petya Koleva; Nafiseh Ghobakhloo; Reed Sutton; Lindsy Ambrosio; Xuanyi Meng; Naomi Hotte; Vivian Nguyen; Karen L Madsen; Levinus A Dieleman; Vivian Huang; Shokrollah Elahi
Journal:  J Crohns Colitis       Date:  2019-02-01       Impact factor: 9.071

Review 4.  Monitoring inflammatory bowel disease during pregnancy: Current literature and future challenges.

Authors:  Tenzin Choden; Rohan Mandaliya; Aline Charabaty; Mark C Mattar
Journal:  World J Gastrointest Pharmacol Ther       Date:  2018-02-06

5.  Intake of dairy protein during pregnancy in IBD and risk of SGA in a Norwegian population-based mother and child cohort.

Authors:  May-Bente Bengtson; Margaretha Haugen; Anne Lise Brantsæter; Geir Aamodt; Morten H Vatn
Journal:  BMC Gastroenterol       Date:  2020-02-03       Impact factor: 3.067

6.  Association Between Gestational Weight Gain and Pregnancy Complications or Adverse Delivery Outcomes in Chinese Han Dichorionic Twin Pregnancies: Validation of the Institute of Medicine (IOM) 2009 Guidelines.

Authors:  Lan Wang; Li Wen; Yangxi Zheng; Wenzheng Zhou; Lingwei Mei; Haoran Li; Chao Tong; Hongbo Qi; Philip N Baker
Journal:  Med Sci Monit       Date:  2018-11-19

7.  Shared decision making in pregnancy in inflammatory bowel disease: design of a patient orientated decision aid.

Authors:  Astrid-Jane Williams; Neda Karimi; Radha Chari; Susan Connor; Mary A De Vera; Levinus A Dieleman; Tawnya Hansen; Kathleen Ismond; Rshmi Khurana; Dawn Kingston; Katie O'Connor; Daniel C Sadowski; Flora Fang-Hwa; Eytan Wine; Yvette Leung; Vivian Huang
Journal:  BMC Gastroenterol       Date:  2021-07-30       Impact factor: 3.067

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.